November 2025 Private Placement Pre-Funded Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
NXTC$5.73+0.61%
NextCure, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$26.23M
Float & O/S:
Inst Own:
DilutionScan read 30 of NextCure, Inc.'s SEC filings and found 3 warrant series, 2 ATM programs, 3 shelf registrations and 1 completed offering on file for NXTC. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
Signal8 Summary
NXTC
Pending merger, near-zero cash runway
Snapshot
NextCure is a clinical-stage biotech burning cash rapidly with no revenue. The structured data shows a cash runway of just 1.5 months, indicating immediate liquidity concerns despite a balance sheet listing $41.8M in cash.
What's Happening Right Now
- : NextCure agreed to merge with privately-held Avere Therapeutics, changing its name to Avere Therapeutics and ticker to AVRX, with current NextCure stockholders retaining approximately 1.21% of the combined company.
- : NextCure reported positive Phase 1 dose escalation data for SIM0505 at ASCO 2026, showing a 55% objective response rate in gynecologic cancers and 52.9% in ovarian cancer.
- : The company announced FDA Fast Track designation for SIM0505 for platinum-resistant ovarian cancer and reported Q1 cash of $29.7 million, sufficient to fund operations into the first half of 2027.
Raise routes on file: effective shelf · latest dilution event 126 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2023
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2025
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2023
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your NXTC trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
